title: Improving psychiatric drug benefit management: IV. Experiences of a pharmacy advisory committee.
authors.affiliation: Temple University School of Medicine, 1316 West Ontario Street, Room 719, Jones Hall, Philadelphia, PA 19140, USA. diane.gottlieb@temple.edu
authors.forename: Diane
authors.initials: D
authors.lastname: Gottlieb
authors.forename: William R
authors.initials: WR
authors.lastname: Dubin
authors.forename: Autumn
authors.initials: A
authors.lastname: Ning
authors.forename: George C
authors.initials: GC
authors.lastname: Gardiner
mesh_terms: D002017:Budgets; D017046:Cost Savings; D034462:Dissent and Disputes; D016527:Drug Costs / Q000706:statistics & numerical data*; D006279:Health Maintenance Organizations / Q000191:economics; D006801:Humans; D007342:Insurance Benefits / Q000191:economics*; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D008484:Medicaid / Q000191:economics*; D001523:Mental Disorders / Q000188:drug therapy / Q000191:economics*; D010414:Pennsylvania; D010606:Pharmacy and Therapeutics Committee; D011619:Psychotropic Drugs / Q000191:economics* / Q000627:therapeutic use
chemical_list: D011619:Psychotropic Drugs